A detailed history of Price T Rowe Associates Inc transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,020,871 shares of APLT stock, worth $9.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,020,871
Previous 30,675 3228.02%
Holding current value
$9.1 Million
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.35 - $8.5 $4.31 Million - $8.42 Million
990,196 Added 3228.02%
1,020,871 $8.68 Million
Q2 2024

Aug 14, 2024

BUY
$4.04 - $6.37 $123,927 - $195,399
30,675 New
30,675 $0
Q2 2021

Aug 16, 2021

SELL
$14.05 - $25.04 $155,814 - $277,693
-11,090 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$16.57 - $28.65 $2,137 - $3,695
129 Added 1.18%
11,090 $208,000
Q4 2020

Feb 16, 2021

BUY
$15.44 - $24.23 $169,237 - $265,585
10,961 New
10,961 $241,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $428M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.